FMR LLC 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-11 09:09 am Sale |
2023-12-08 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 3,803,214 4.842% |
-3,102,208 (-44.92%) |
Filing |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 6,905,422 11.209% |
511,609 (+8.00%) |
Filing |
| 2022-08-10 08:10 am Purchase |
2022-08-09 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 6,393,813 10.976% |
1,392,331 (+27.84%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 5,001,482 10.382% |
159,757 (+3.30%) |
Filing |
| 2021-12-28 12:05 pm Purchase |
2021-12-28 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 4,841,725 10.051% |
1,522,263 (+45.86%) |
Filing |
| 2021-06-23 11:08 am Purchase |
2021-06-22 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 3,319,462 7.198% |
3,319,462 (New Position) |
Filing |